The authors reported that receptor activator of nuclear factor κB ligand (RANKL; TNFSF11) enhanced breast cancer metastasis to the TE bone and formation of osteolytic lesions (Seib et al., 2015). This evidence concerns the gene TNFSF11 and breast cancer.